Prenetics Global achieved breakthrough growth in 2025, with revenue of approximately $92 million, driven primarily by IM8, its consumer-facing nutritional supplement brand. The brand achieved annual recurring revenue of $120 million, growing from approximately $581,000 in the first month to monthly revenue of approximately $10 million in December. IM8 achieved a gross margin of 63% during the year, and the company projects 2026 revenue of $180 million to $200 million with gross margins at or exceeding 60%. Management has divested non-core assets, currently holding approximately $160 million in liquid assets with no debt, targeting profitability by Q4 2027.